Works by Leonowens, Cathrine


Results: 6
    1
    2

    Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.

    Published in:
    2020
    By:
    • Tolcher, Anthony W.;
    • Kurzrock, Razelle;
    • Valero, Vincente;
    • Gonzalez, Rene;
    • Heist, Rebecca S.;
    • Tan, Antoinette R.;
    • Means-Powell, Julie;
    • Werner, Theresa L.;
    • Becerra, Carlos;
    • Wang, Chenxi;
    • Leonowens, Cathrine;
    • Kalyana-Sundaram, Shanker;
    • Kleha, Joseph F.;
    • Gauvin, Jennifer;
    • D'Amelio, Anthony M.;
    • Ellis, Catherine;
    • Ibrahim, Nageatte;
    • Yan, Li;
    • D'Amelio, Anthony M Jr
    Publication type:
    journal article
    3
    4
    5
    6